ClinicalTrials.Veeva

Menu

Transcranial Direct Current Stimulation - Tobacco Use Disorder

C

Central Institute of Mental Health, Mannheim

Status

Completed

Conditions

Tobacco Use Disorder

Treatments

Device: Sham tDCS
Device: tDCS

Study type

Interventional

Funder types

Other

Identifiers

NCT03691805
tDCS-TUD

Details and patient eligibility

About

This study aims to detect how transcranial direct current stimulation (tDCS) affects smokers' inhibitory control, craving and consumption of tobacco goods.

Full description

Participating smokers are to receive anodal transcranial direct current stimulation of the right dorsolateral prefrontal cortex (rDLPFC) for 20 minutes on five consecutive days. Neuropsychological tests on inhibitory control and interviews on smoking habits and craving will be applied before and after the first stimulation as well as after the fifth stimulation.

After a follow-up period of three days, smoking behaviour will be assessed in a telephone interview.

Changes in inhibitory control and smoking behaviour will be compared between an active and a sham stimulation group.This way the effects of transcranial direct current stimulation on tobacco use disorder are to be clarified.

Enrollment

44 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • tobacco use disorder
  • normal or correctable eyesight
  • sufficient ability to communicate with the investigators, to answer questions in oral and written form
  • fully informed consent
  • written informed consent

Exclusion criteria

  • withdrawal of the declaration of consent
  • exclusion criteria for tDCS (metal implants in the head, acute eczema, known epilepsy)
  • severe internal, neurological or psychiatric comorbidity
  • pharmacotherapy with psychoactive substances within the last 14 days
  • axis-I disorder according to ICD-10 and DSM 5 (except tobacco use disorder)
  • positive urin drug screening (cannabis, amphetamine, opiates, benzodiazepines, cocaine)
  • pregnancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

44 participants in 2 patient groups

anodal tDCS over rDLPFC
Active Comparator group
Description:
Participants will receive anodal tDCS (transcranial direct current stimulation) of the right dorsolateral prefrontal Cortex (DLPFC).
Treatment:
Device: tDCS
sham tDCS
Sham Comparator group
Description:
Participants will receive sham tDCS (transcranial direct current stimulation) of the DLPFC.
Treatment:
Device: Sham tDCS

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems